93 related articles for article (PubMed ID: 35275495)
1. Persistence of Platelets Activation Prior to Second Doses of Covid-19 Vaccine After Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Roberge G; Carrier M
Clin Appl Thromb Hemost; 2022; 28():10760296221086283. PubMed ID: 35275495
[No Abstract] [Full Text] [Related]
2. Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2.
Lindhoff-Last E; Schoenborn L; Piorkowski M; Herold J; Greinacher A; Sheppard JA; Warkentin TE
Thromb Haemost; 2022 Feb; 122(2):304-307. PubMed ID: 34794199
[No Abstract] [Full Text] [Related]
3. Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.
Crickx E; Moulis G; Ebbo M; Terriou L; Briantais A; Languille L; Limal N; Guillet S; Michel M; Mahevas M; Godeau B
Br J Haematol; 2021 Dec; 195(5):703-705. PubMed ID: 34467525
[No Abstract] [Full Text] [Related]
4. Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Uzun G; Pelzl L; Singh A; Bakchoul T
Front Immunol; 2022; 13():837629. PubMed ID: 35273612
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 timeline of events.
Webster P
Nat Med; 2021 Dec; 27(12):2054-2055. PubMed ID: 34907389
[No Abstract] [Full Text] [Related]
6. Potential Anionic Substances Binding to Platelet Factor 4 in Vaccine-Induced Thrombotic Thrombocytopenia of ChAdOx1-S Vaccine for SARS-CoV-2.
Pang X; Liu H; He X; Ji T; Zhu Y; Cui Y
Front Immunol; 2021; 12():782335. PubMed ID: 35095856
[TBL] [Abstract][Full Text] [Related]
7. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.
Osmanodja B; Schreiber A; Schrezenmeier E; Seelow E
BMC Nephrol; 2021 Dec; 22(1):411. PubMed ID: 34895163
[TBL] [Abstract][Full Text] [Related]
8. Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors.
Chan WY; Howells L; Wilson W; Sanchez E; Ainley L; Chavda SJ; Dowling E; Correia N; Lecat CSY; McMillan A; Wisniowski B; Mahmood S; Papanikolaou X; Lee L; Sive J; Kyriakou C; Wechalekar A; Popat R; Rabin N; Nastouli E; Yong KL; Xu K
Br J Haematol; 2022 Feb; 196(3):e21-e26. PubMed ID: 34632575
[No Abstract] [Full Text] [Related]
9. Immunogenicity and efficacy of heterologous ChAdOx1-BNT162b2 vaccination.
Pozzetto B; Legros V; Djebali S; Barateau V; Guibert N; Villard M; Peyrot L; Allatif O; Fassier JB; Massardier-Pilonchéry A; Brengel-Pesce K; Yaugel-Novoa M; Denolly S; Boson B; Bourlet T; Bal A; Valette M; Andrieu T; Lina B; ; Cosset FL; Paul S; Defrance T; Marvel J; Walzer T; Trouillet-Assant S
Nature; 2021 Dec; 600(7890):701-706. PubMed ID: 34673755
[TBL] [Abstract][Full Text] [Related]
10. Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.
Groß R; Zanoni M; Seidel A; Conzelmann C; Gilg A; Krnavek D; Erdemci-Evin S; Mayer B; Hoffmann M; Pöhlmann S; Liu W; Hahn BH; Beil A; Kroschel J; Jahrsdörfer B; Schrezenmeier H; Kirchhoff F; Münch J; Müller JA
EBioMedicine; 2022 Jan; 75():103761. PubMed ID: 34929493
[TBL] [Abstract][Full Text] [Related]
11. Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).
Paulsen FO; Schaefers C; Langer F; Frenzel C; Wenzel U; Hengel FE; Bokemeyer C; Seidel C
Blood; 2021 Sep; 138(11):996-999. PubMed ID: 34297792
[No Abstract] [Full Text] [Related]
12. VITT and Second Doses of Covid-19 Vaccine.
Lacy J; Pavord S; Brown KE
N Engl J Med; 2022 Jan; 386(1):95. PubMed ID: 34936738
[No Abstract] [Full Text] [Related]
13. Coincidental Onset of Ocular Myasthenia Gravis Following ChAdOx1 n-CoV-19 Vaccine against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Galassi G; Rispoli V; Iori E; Ariatti A; Marchioni A
Isr Med Assoc J; 2022 Jan; 24(1):9-10. PubMed ID: 35077038
[TBL] [Abstract][Full Text] [Related]
14. Unusual Site of Deep Vein Thrombosis After mRNA Coronavirus Disease-2019 (COVID-19) Vaccination.
Hasegawa T; Yazaki Y
Circ J; 2022 Mar; 86(4):723. PubMed ID: 34840204
[No Abstract] [Full Text] [Related]
15. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.
Lazarus R; Baos S; Cappel-Porter H; Carson-Stevens A; Clout M; Culliford L; Emmett SR; Garstang J; Gbadamoshi L; Hallis B; Harris RA; Hutton D; Jacobsen N; Joyce K; Kaminski R; Libri V; Middleditch A; McCullagh L; Moran E; Phillipson A; Price E; Ryan J; Thirard R; Todd R; Snape MD; Tucker D; Williams RL; Nguyen-Van-Tam JS; Finn A; Rogers CA;
Lancet; 2021 Dec; 398(10318):2277-2287. PubMed ID: 34774197
[TBL] [Abstract][Full Text] [Related]
16. Papilledema due to Vaccine-Induced Thrombocytopenia.
Qian J; Lutchman C; Margolin E
Ophthalmology; 2022 Feb; 129(2):190. PubMed ID: 35065733
[No Abstract] [Full Text] [Related]
17. Immune Thrombocytopenia (ITP): Relapse Versus de novo After COVID-19 Vaccination.
Al-Ahmad M; Al Rasheed M; Shalaby N; Rodriguez-Bouza T; Altourah L
Clin Appl Thromb Hemost; 2022; 28():10760296211073920. PubMed ID: 35108113
[No Abstract] [Full Text] [Related]
18. The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia.
Uzun G; Althaus K; Singh A; Möller P; Ziemann U; Mengel A; Rosenberger P; Guthoff M; Petzold GC; Müller J; Büchsel M; Feil K; Henkes H; Heyne N; Maschke M; Limpach C; Nagel S; Sachs UJ; Fend F; Bakchoul T
Blood; 2021 Sep; 138(11):992-996. PubMed ID: 34166507
[No Abstract] [Full Text] [Related]
19. COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis.
Bilotta C; Perrone G; Adelfio V; Spatola GF; Uzzo ML; Argo A; Zerbo S
Front Immunol; 2021; 12():729251. PubMed ID: 34912330
[TBL] [Abstract][Full Text] [Related]
20. Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
Gram MA; Nielsen J; Schelde AB; Nielsen KF; Moustsen-Helms IR; Sørensen AKB; Valentiner-Branth P; Emborg HD
PLoS Med; 2021 Dec; 18(12):e1003874. PubMed ID: 34919548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
